Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia

ClinicalTrials.gov ID: NCT00532311

Public ClinicalTrials.gov record NCT00532311. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 6:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg or Placebo When Co-administered With Statins in Subjects With Hypercholesterolemia, With an Optional Open-Label Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with statins on cholesterol levels in subjects with hypercholesterolemia

Study identification

NCT ID
NCT00532311
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
411 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2007 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Apr 2008 (Actual)
Last update posted
Jun 22, 2016

2007 – 2008

United States locations

U.S. sites
86
U.S. states
34
U.S. cities
86
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Huntsville Alabama — —
Not listed Mobile Alabama — —
Not listed Tuscaloosa Alabama — —
Not listed Chandler Arizona — —
Not listed Gilbert Arizona — —
Not listed Glendale Arizona — —
Not listed Tucson Arizona — —
Not listed Artesia California — —
Not listed Long Beach California — —
Not listed Santa Ana California — —
Not listed Santa Rosa California — —
Not listed Tustin California — —
Not listed Walnut Creek California — —
Not listed Colorado Springs Colorado — —
Not listed Golden Colorado — —
Not listed Washington D.C. District of Columbia — —
Not listed Coral Gables Florida — —
Not listed Fort Meyers Florida — —
Not listed Hollywood Florida — —
Not listed Jacksonville Florida — —
Not listed Miami Florida — —
Not listed New Port Richey Florida — —
Not listed Pembroke Pines Florida — —
Not listed Pensacola Florida — —
Not listed Pinellas Park Florida — —
Not listed Sarasota Florida — —
Not listed St. Petersburg Florida — —
Not listed West Palm Beach Florida — —
Not listed Dunwoody Georgia — —
Not listed Idaho Falls Idaho — —
Not listed Aurora Illinois — —
Not listed Chicago Illinois — —
Not listed Evansville Indiana — —
Not listed Indianapolis Indiana — —
Not listed Iowa City Iowa — —
Not listed Overland Park Kansas — —
Not listed Wichita Kansas — —
Not listed Louisville Kentucky — —
Not listed CantonAuburn Maine — —
Not listed Scarborough Maine — —
Not listed Baltimore Maryland — —
Not listed Haverhill Massachusetts — —
Not listed Ann Arbor Michigan — —
Not listed Brooklyn Center Minnesota — —
Not listed Edina Minnesota — —
Not listed Olive Branch Mississippi — —
Not listed St Louis Missouri — —
Not listed Billings Montana — —
Not listed Margate City New Jersey — —
Not listed Wilwood New Jersey — —
Not listed Asheville North Carolina — —
Not listed Charlotte North Carolina — —
Not listed Durham North Carolina — —
Not listed Hickory North Carolina — —
Not listed Raleigh North Carolina — —
Not listed Salisbury North Carolina — —
Not listed Statesville North Carolina — —
Not listed Wilmington North Carolina — —
Not listed Winston-Salem North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Kettering Ohio — —
Not listed Mentor Ohio — —
Not listed Zanesville Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Portland Oregon — —
Not listed Altoona Pennsylvania — —
Not listed Dowington Pennsylvania — —
Not listed Sellerville Pennsylvania — —
Not listed Warwick Rhode Island — —
Not listed Goose Creek South Carolina — —
Not listed Greer South Carolina — —
Not listed Mt. Pleasant South Carolina — —
Not listed Simpsonville South Carolina — —
Not listed Bristol Tennessee — —
Not listed Austin Texas — —
Not listed Corpus Christi Texas — —
Not listed Dallas Texas — —
Not listed Houston Texas — —
Not listed Irving Texas — —
Not listed San Antonio Texas — —
Not listed Salt Lake City Utah — —
Not listed Burke Virginia — —
Not listed Norfolk Virginia — —
Not listed Richmond Virginia — —
Not listed Wauwatosa Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00532311, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2016 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00532311 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →